Opioid ketal compounds and uses thereof
AssigneeRhodes Technologies
InventorsRobert J. Kupper, Raymond C. Glowaky
Life of this patent
Estimating the term…
Abstract
This invention relates to opioid ketal compounds of Formula (I), Formula (II), or Formula (III): or a pharmaceutically acceptable salts thereof, wherein R1 is H or CH3, R2 is H or OH, n is 0, 1, 2 or 3, R3 and R4 are independently H or optionally substituted C1-C4 alkyl, or when n is 0, then R3 and R4 and the carbon atoms to which they are attached together form six, or seven membered ring, which is optionally mono or disubstituted by C1-C4 alkyl. The invention also relates to oxycodone ketal compounds of Formula (IV) or (V): or a pharmaceutically acceptable salts thereof. The invention also relates to the use of such compounds for the treatment, prevention, or amelioration of pain.
Claims7
A pharmaceutical composition, comprising a compound of Formula I:
- or a pharmaceutically acceptable salt thereof, wherein
- R1 is H or CH3,
- R2 is H,
- n is 0, 1, 2 or 3,
- R3 and R4 are independently H or optionally substituted C1-C4 alkyl, or
- when n is 0, then R3 and R4 and the carbon atoms to which they are attached together form a six or seven membered ring, which is optionally mono or disubstituted by C1-C4 alkyl, and wherein when R3 or R4 is other than hydrogen, the carbon atoms labeled * and ** are independently in the R or S configuration;
- with the proviso that the compound is not hydrocodone ethyleneglycol ketal or hydromorphone ethyleneglycol ketal,
- or a mixture of compounds of Formula I or the pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.